Press Release Contact
Press release:
OWP Pharmaceuticals Announces Commercial Product Availability of SUBVENITE® (lamotrigine) Oral Suspension in U.S. Market
January 12, 2026, 14:13 GMT
For questions about this press release, please contact the person or organization listed below.
Sara Gao
OWP PHARMACEUTICALS